跳至主要内容
临床试验/NCT00453713
NCT00453713已完成不适用

Determinants of Outcome in Diffuse Parenchymal Lung Disease

Columbia University1 个研究点 分布在 1 个国家目标入组 565 人开始时间: 2006年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
565
试验地点
1

研究概览

简要总结

The purpose of this study is to identify factors that contribute to higher mortality rates among blacks and Hispanics with diffuse parenchymal lung disease.

详细描述

It is well known that both socioeconomic and biological factors may contribute to race- and ethnicity-based health disparities. Black and Hispanic Americans have worse access to healthcare services and tend to receive care from physicians who cannot themselves access the same services for their patients that physicians who care for white patients can. These factors may play important roles in the development and maintenance of health disparities. In addition, biological differences may contribute to disparities. We propose to identify factors that explain survival disparities in a group of lung diseases called diffuse parenchymal lung diseases (DPLDs), including a severe form of DPLD called idiopathic pulmonary fibrosis (IPF). We will follow patients with DPLD at our center and measure both social and biological factors to try to identify the factors that lead to survival disparities between races. Results of this study will be used to design clinical trials aimed at reducing these disparities.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of IPF or other DPLD according to ATS criteria
  • Signed informed consent

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David J. Lederer, M.D.

Irving Assistant Professor of Medicine (in Pediatrics)

Columbia University

研究点 (1)

Loading locations...

相似试验